Log in
Enquire now
‌

US Patent 11130819 Antibodies

Patent 11130819 was granted and assigned to Genmab A/S on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Genmab A/S
Current Assignee
‌
Genmab A/S
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11130819
Patent Inventor Names
David Satijn0
Bart E. C. G. De Goeij0
Rik Rademaker0
Sjeng Horbach0
Dennis Verzijl0
Edward N. Van Den Brink0
Esther C. W. Breij0
Kristel Kemper0
...
Date of Patent
September 28, 2021
Patent Application Number
20210412
Date Filed
April 12, 2021
Patent Citations Received
‌
US Patent 11970544 Antibodies
0
Patent abstract

The present invention relates to antibodies binding to 5T4, including bispecific antibodies binding to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11130819 Antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.